Project Manager – Clinical Programmes



Contract type


Contracted hours




Job description

Oxular is looking for an experienced Project Manager who can drive development of retinal therapeutic clinical programmes.

The ideal candidate has scientific training in either chemistry or biology, brings 5 or more years’ experience in drug development, is proactive, takes initiative, and is not afraid to roll up their sleeves to ensure quality completion of a job.

The person must be well organised and skilled to provide oversight and administration across key functional areas involved in drug development.  The person must be adept at using project management tools, and preparing and presenting communication documents, and driven to ensure programme deliverables are completed on time and within budget.

Key responsibilities

  • Coordinate cross functional administration and oversight of R&D teams
  • Develop and maintain program development plans, including detailed activities across formulation, preclinical, regulatory and clinical functions, including budget and timelines
  • Actively manage external contract research organisations and consultants
  • Coordinate and actively participation in the preparation, review and submission of regulatory briefing documents
  • Deliver program updates and highlight issues, ensuring open, transparent communication with the company
  • Identify potential risks to project progression and generate back-up and or mitigation plans

Education & experience

  • >5yrs in Project Management Biotech/ Pharma
  • PhD in Biology, Chemistry, Biology, or related life science field
  • A track-record of managing projects from discovery through translation into human clinical trials
  • Manage and coordinate activities with contract research organisations
  • Excellent written, oral, and organisational skills
  • Experienced with project tracking tools such as Microsoft project
  • Strong Microsoft Office skills
About Oxular Limited

“One treatment a year. Life changing.”

Oxular is developing technology to transform the treatment of retinal disease, offering patients life-changing solutions to their unmet needs. Oxular’s sustained-release formulations are engineered to last up to one year following single administration and perform in specific small spaces in the eye. This approach provides unique and precise drug distribution to tissues specifically involved in retinal diseases. Oxular’s drug administration technology is engineered to access these critical tissues through minimally-invasive delivery. This novel combination aims to substantially improve patient quality of life by increasing therapeutic effectiveness and patient safety, while reducing side-effects and minimizing the frequency of treatments. Oxular’s product development pipeline includes treatments for prevalent retinal diseases, such as diabetic macular edema and age-related macular degeneration, as well as rare and orphan indications, including treatments for ocular cancers.

Covid-19 recruitment conditions

Interviews will take place remotely. In-office or in-lab work roles will adhere to government guidelines for social distancing, PPE provision, temperature screening and any required cleaning, disinfection or other guidelines in place.

Scroll to Top